Drug:
Reaction: BLOOD GLUCOSE INCREASED
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26444167 |
US |
44 | |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 502 | 26444260 |
US |
58 | 2 |
Blood glucose increased, Illness, |
||||
DAPAGLIFLOZIN, |
||||
| 503 | 26444507 |
US |
78 | 2 |
Blood glucose increased, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 504 | 26445249 |
US |
77 | 2 |
Anti-neutrophil cytoplasmic antibody positive vasculitis, Pneumonia, Acute kidney injury, Blood glucose increased, Albumin globulin ratio increased, Hypoacusis, Hypertension, Dizziness, Weight decreased, Arthralgia, Increased tendency to bruise, Anxiety, Gastrooesophageal reflux disease, Anaemia, Metabolic acidosis, Asthenia, |
||||
ERYTHROPOIETIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, AVACOPAN, ALBUTEROL SULFATE, CARVEDILOL, FERROUS SULFATE, FLUCONAZOLE, HYDRALAZINE HYDROCHLORIDE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, LATANOPROST, LOSARTAN, PREGABALIN, PANTOPRAZOLE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, TIZANIDINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMLODIPINE, RITUXIMAB, |
||||
| 505 | 26445452 |
US |
1 | |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 506 | 26445461 |
IN |
51 | 2 |
Diabetes mellitus inadequate control, Blood glucose increased, Counterfeit product administered, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 507 | 26445813 |
US |
45 | 2 |
Hypertriglyceridaemia, Pancreatitis relapsing, Endometriosis, Uterine leiomyoma, Pleural effusion, Anaemia, Blood alkaline phosphatase decreased, Blood glucose increased, Glycosylated haemoglobin increased, Loss of employment, |
||||
ICOSAPENT ETHYL, ICOSAPENT ETHYL CAPSULES, FENOFIBRATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EMPAGLIFLOZIN, EMPAGLIFLOZIN, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FERROUS SULFATE, FERROUS SULFATE, |
||||
| 508 | 26445914 |
US |
||
Renal impairment, Decreased appetite, Weight decreased, Pruritus, Joint swelling, Blood potassium decreased, Blood urea increased, Haemoglobin decreased, Blood calcium increased, Blood glucose increased, Red blood cell count decreased, Haematocrit decreased, Mean cell haemoglobin concentration decreased, Red cell distribution width increased, Platelet count decreased, Blood creatinine increased, Anaemia, |
||||
IVOSIDENIB, |
||||
| 509 | 26445917 |
US |
72 | 2 |
Diarrhoea, Dehydration, Blood glucose increased, Abdominal pain upper, Asthenia, Constipation, Blood potassium decreased, Back pain, |
||||
PANCRELIPASE, PANCRELIPASE, PANCRELIPASE, HYDROXYZINE, INSULIN GLARGINE, INSULIN LISPRO, LOSARTAN, |
||||
| 510 | 26436370 |
CA |
53 | 2 |
Rheumatoid arthritis, Infusion related reaction, Pain, Helicobacter infection, Dysphagia, Abdominal pain upper, Contusion, Gastrointestinal pain, Pharyngeal mass, Arthralgia, Pain in extremity, Procedural pain, Carpal tunnel syndrome, Walking aid user, Nerve compression, Myalgia, Weight increased, Blood glucose increased, Blood pressure fluctuation, Stress ulcer, Abdominal discomfort, Throat irritation, Food intolerance, Fatigue, Foot operation, Diarrhoea, Gastritis, Neck pain, Ill-defined disorder, |
||||
REPAGLINIDE, HYDROXYCHLOROQUINE, SITAGLIPTIN, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LANSOPRAZOLE, RITUXIMAB, RITUXIMAB, DESOXIMETASONE, SULFASALAZINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 511 | 26437069 |
US |
70 | 1 |
Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 512 | 26437225 |
US |
54 | 2 |
Cerebral haemorrhage, Headache, Diabetes mellitus inadequate control, Blood glucose increased, Product dispensing error, Product prescribing issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 513 | 26437494 |
US |
63 | 1 |
Blood glucose increased, Weight increased, Fatigue, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 514 | 26437579 |
US |
64 | 1 |
Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 515 | 26437988 |
IN |
2 | |
Blood glucose increased, Blood glucose abnormal, Platelet count decreased, Renal impairment, Adrenal disorder, Blood sodium decreased, Blood potassium decreased, Blood pressure fluctuation, Blood cholesterol abnormal, |
||||
RITUXIMAB, |
||||
| 516 | 26438215 |
US |
2 | |
Blood glucose increased, Product use issue, Product dose omission issue, Weight decreased, Insurance issue, |
||||
SITAGLIPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 517 | 26438383 |
EU |
12 | 2 |
Hypotension, Headache, Pruritus, Erythema, Temperature regulation disorder, Skin lesion, Skin discolouration, Dizziness, Presyncope, Blood glucose increased, Abdominal pain, Cheilitis, Somnolence, White blood cell count decreased, Fatigue, Lymphopenia, Vomiting, Nausea, Pyrexia, Blood bilirubin decreased, |
||||
| 518 | 26438693 |
US |
67 | 1 |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 519 | 26438929 |
US |
2 | |
Blood glucose increased, Intentional product misuse, Product storage error, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 520 | 26439704 |
US |
1 | |
Blood glucose increased, Visual impairment, Wrong technique in product usage process, |
||||
| 521 | 26439869 |
US |
81 | 1 |
Blood glucose increased, Incorrect dose administered, Device issue, |
||||
INSULIN GLARGINE, |
||||
| 522 | 26440127 |
CL |
76 | 2 |
Platelet count decreased, Rectal haemorrhage, Gait disturbance, Anaemia, Rectal lesion, Haemorrhage, White blood cell count decreased, Blood urine present, Cystitis radiation, Metastases to bladder, Electrocardiogram repolarisation abnormality, Atrioventricular conduction time shortened, Electrocardiogram PR shortened, Electrocardiogram ST-T segment abnormal, Excessive granulation tissue, Blood glucose increased, Haemoglobin decreased, Neutrophil count decreased, Red cell distribution width increased, Anisocytosis, Poikilocytosis, Erythroblast count increased, Elliptocytosis, Protein total decreased, Blood uric acid increased, Blood chloride increased, Fibrin D dimer increased, Red blood cell sedimentation rate increased, Rouleaux formation, Blood urea increased, Mean cell volume increased, Mean cell haemoglobin increased, Macrocytosis, Laboratory test abnormal, Blood calcium decreased, Blood albumin decreased, Lymphocyte count decreased, Feeling abnormal, Fatigue, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, FULVESTRANT, DENOSUMAB, ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS, |
||||
| 523 | 26440190 |
CO |
83 | 2 |
Gastroenteritis, Blood glucose increased, |
||||
ORAL SEMAGLUTIDE, EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, INSULIN GLARGINE, LOSARTAN, PREGABALIN, APIXABAN, |
||||
| 524 | 26440335 |
EU |
70 | 2 |
Cataract, Diarrhoea, Fungal infection, Blood glucose increased, Fatigue, Thirst, Poor quality sleep, Hypertension, Hypercholesterolaemia, Fibromyalgia, Binge eating, |
||||
DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EMPAGLIFLOZIN, SITAGLIPTIN, LOSARTAN, BISOPROLOL FUMARATE, |
||||
| 525 | 26440389 |
CA |
56 | 2 |
Arthralgia, Cough, Constipation, Peripheral swelling, Vaginal haemorrhage, Pneumonia, Blood pressure diastolic increased, Blood pressure increased, Dyspepsia, Diarrhoea, Fungal pharyngitis, Back pain, Reading disorder, Hypophagia, Osteoarthritis, Memory impairment, Fatigue, Dyslexia, Contusion, International normalised ratio decreased, Hepatic steatosis, Muscle spasms, Urticaria, Pain, Coronavirus test positive, Inflammation, Tongue coated, Cholelithiasis, Gout, Haematochezia, Ankylosing spondylitis, Injection site pain, Breast discharge, Oropharyngeal pain, Hyperglycaemia, Weight decreased, Liver injury, Blood cholesterol increased, Dehydration, Atrial fibrillation, Blood glucose increased, Feeding disorder, Dizziness, Tooth infection, Product dose omission issue, Dysphonia, Burning sensation, Malaise, Abdominal discomfort, Fungal infection, Anticoagulation drug level above therapeutic, Gamma-glutamyltransferase increased, Vocal cord operation, Dyspnoea, Joint swelling, Diabetes mellitus inadequate control, Pharyngeal cyst, Blood glucose fluctuation, Dry mouth, Spontaneous haemorrhage, International normalised ratio increased, Productive cough, Dyspnoea exertional, Decreased appetite, Blood pressure abnormal, Blood glucose abnormal, Haematoma, Inappropriate schedule of product administration, COVID-19, Pneumonitis, Drug hypersensitivity, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FUROSEMIDE, COLCHICINE, WARFARIN, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, FUROSEMIDE, SPIRONOLACTONE, SPIRONOLACTONE, PHYTONADIONE, PHYTONADIONE, LEVOTHYROXINE SODIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FLUCONAZOLE, FLUCONAZOLE, FLUCONAZOLE, FLUCONAZOLE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, AMOXICILLIN, CORTISONE ACETATE, CYCLOBENZAPRINE, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, AMOXICILLIN AND CLAVULANATE POTASSIUM, |
||||
| 526 | 26440527 |
JP |
1 | |
Blood glucose increased, Tremor, Hypoaesthesia, Weight decreased, |
||||
TIRZEPATIDE, |
||||
| 527 | 26440552 |
US |
1 | |
Oxygen saturation abnormal, Blood pressure increased, Blood glucose increased, Drug dose omission by device, Wrong technique in product usage process, |
||||
INSULIN DEGLUDEC, |
||||
| 528 | 26440912 |
US |
64 | |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 529 | 26440916 |
GB |
64 | 1 |
Cerebrovascular accident, Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 530 | 26440995 |
US |
60 | 2 |
Labyrinthine fistula, Constipation, Wheezing, Headache, Bone pain, Myalgia, Fatigue, Asthma, Hypercalcaemia, Glycosylated haemoglobin increased, Vitamin B1 decreased, Blood glucose increased, Blood sodium decreased, |
||||
ASFOTASE ALFA, ATENOLOL, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 531 | 26443692 |
71 | 1 | |
Blood glucose increased, Glycosylated haemoglobin increased, |
||||
RELUGOLIX, ERGOCALCIFEROL, ROSUVASTATIN, |
||||
| 532 | 26431252 |
US |
65 | 2 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 533 | 26431315 |
US |
69 | 1 |
Blood glucose increased, Accidental exposure to product, Exposure via skin contact, |
||||
INSULIN GLARGINE, |
||||
| 534 | 26431329 |
US |
1 | |
Blood glucose increased, Product storage error, Surgery, |
||||
INSULIN GLARGINE, |
||||
| 535 | 26431572 |
US |
68 | 1 |
Surgery, Nausea, Vomiting, Diarrhoea, Incoherent, Gait inability, Blood glucose increased, Dizziness, Somnolence, Hangover, Dyspnoea, Tinnitus, Therapeutic procedure, Intentional dose omission, Product storage error, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, SEMAGLUTIDE, ORAL SEMAGLUTIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, OLANZAPINE, |
||||
| 536 | 26431595 |
US |
2 | |
Blood glucose decreased, Pain, Hair texture abnormal, Blood glucose increased, Anxiety, Fatigue, Decreased appetite, Disease progression, |
||||
OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, ATENOLOL, ALBUTEROL SULFATE, ALPRAZOLAM, LOSARTAN POTASSIUM, LOSARTAN, ERGOCALCIFEROL, AMOXICILLIN AND CLAVULANATE POTASSIUM, |
||||
| 537 | 26431909 |
|||
Pain, Blood glucose increased, |
||||
ROZANOLIXIZUMAB, |
||||
| 538 | 26432684 |
US |
||
Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN LISPRO, |
||||
| 539 | 26432710 |
EU |
69 | 1 |
Pneumonia, Pneumonia, Blood glucose increased, |
||||
DEXAMETHASONE, DEXAMETHASONE, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, INSULIN GLULISINE, INSULIN DEGLUDEC AND LIRAGLUTIDE, ERTUGLIFLOZIN, NEBIVOLOL HYDROCHLORIDE, ALLOPURINOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 540 | 26432775 |
53 | ||
Blood glucose increased, International normalised ratio decreased, |
||||
OLEZARSEN SODIUM, INSULIN LISPRO, GABAPENTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BUPROPION, DULOXETINE HYDROCHLORIDE, DULOXETINE, METOPROLOL TARTRATE, METOPROLOL, FENOFIBRATE, TIRZEPATIDE, INSULIN DEGLUDEC, PIOGLITAZONE, EMPAGLIFLOZIN, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL, OMEGA-3-ACID ETHYL ESTERS, EZETIMIBE, WARFARIN, |
||||
| 541 | 26433074 |
US |
59 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 542 | 26433714 |
US |
76 | 2 |
Blood glucose increased, Accidental underdose, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, |
||||
| 543 | 26433850 |
US |
46 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, PREDNISONE, |
||||
| 544 | 26434066 |
US |
1 | |
Blood glucose increased, Hyperglycaemia, |
||||
INSULIN GLARGINE, |
||||
| 545 | 26434414 |
US |
67 | 1 |
Blood glucose increased, Dizziness, Drug ineffective, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 546 | 26434494 |
US |
||
Blood glucose increased, |
||||
| 547 | 26434653 |
US |
2 | |
Diabetes mellitus, Blood glucose increased, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 548 | 26434999 |
US |
92 | |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 549 | 26435275 |
US |
77 | 1 |
Delirium, Urinary tract infection, Fall, Skin abrasion, Asthenia, Blood glucose increased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, EMPAGLIFLOZIN, |
||||
| 550 | 26435368 |
CO |
2 | |
Abdominal pain upper, Blood glucose increased, Mobility decreased, Vomiting, Arthralgia, Product use issue, |
||||
AFLIBERCEPT, |
||||
| 551 | 26435399 |
US |
75 | 2 |
Small intestinal obstruction, Abdominal pain lower, Abdominal distension, Crohn^s disease, Constipation, Flatulence, Chills, Malaise, Insomnia, Discomfort, Feeling abnormal, C-reactive protein increased, Appendicitis noninfective, Appendicitis, Abdominal adhesions, White blood cell count increased, Neutrophil percentage increased, Lymphocyte percentage decreased, Blood glucose increased, Aspartate aminotransferase increased, Alanine aminotransferase increased, |
||||
RISANKIZUMAB-RZAA, DEXTROAMPHETAMINE SULFATE, ESTRADIOL, LINACLOTIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 552 | 26435752 |
BR |
57 | 2 |
Impaired gastric emptying, Diabetic neuropathy, Blood glucose increased, Constipation, Weight increased, Faeces hard, Increased appetite, Vulvovaginal dryness, Anal fissure, Dry skin, Dry mouth, |
||||
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, ENALAPRIL, AMLODIPINE BESYLATE, PITAVASTATIN CALCIUM, PITAVASTATIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 553 | 26435779 |
US |
||
Goitre, Pancreatic disorder, Hunger, Blood glucose increased, |
||||
TIRZEPATIDE, INSULIN GLARGINE, |
||||
| 554 | 26435843 |
US |
75 | 1 |
Haematochezia, Intestinal obstruction, Blood glucose decreased, Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 555 | 26436001 |
US |
74 | 1 |
Blood glucose increased, Inability to afford medication, Product administration interrupted, |
||||
SITAGLIPTIN, |
||||
| 556 | 26426606 |
US |
61 | 1 |
Blood glucose increased, |
||||
ABEMACICLIB, EMPAGLIFLOZIN, |
||||
| 557 | 26426670 |
US |
2 | |
Blood glucose increased, Hypertension, Psoriatic arthropathy, |
||||
RISANKIZUMAB-RZAA, |
||||
| 558 | 26426842 |
US |
72 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 559 | 26426863 |
US |
||
Blood glucose increased, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 560 | 26427700 |
EU |
58 | 1 |
Glycosylated haemoglobin increased, Blood cholesterol increased, Blood glucose increased, Blood triglycerides increased, |
||||
RISANKIZUMAB-RZAA, |
||||
| 561 | 26427722 |
US |
55 | 1 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 562 | 26427862 |
US |
2 | |
Syncope, Metastases to bone, Rash pruritic, Blood glucose increased, Frequent bowel movements, Nausea, |
||||
CAPIVASERTIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, FULVESTRANT, BIOTIN, FISH OIL, |
||||
| 563 | 26428238 |
US |
91 | 2 |
Hypothyroidism, Blood glucose increased, Dizziness, Blood glucose decreased, Back pain, Infection, |
||||
INSULIN ASPART, INSULIN DEGLUDEC, |
||||
| 564 | 26428851 |
US |
2 | |
Osteomyelitis, Cauda equina syndrome, Dementia, Wheelchair user, Discharge, Product quality issue, Blood glucose increased, Diabetes mellitus inadequate control, Glycosylated haemoglobin increased, Exposure to fungus, |
||||
INSULIN ASPART, INSULIN GLARGINE, |
||||
| 565 | 26428933 |
US |
86 | 1 |
Joint effusion, Arthralgia, Pain in extremity, Blood glucose increased, Injection site bruising, Injection site swelling, |
||||
PREDNISONE, |
||||
| 566 | 26428948 |
US |
2 | |
Blood glucose increased, |
||||
| 567 | 26429013 |
US |
46 | 1 |
Arteriosclerosis coronary artery, Angina unstable, Blood glucose increased, Polydipsia, Alanine aminotransferase increased, |
||||
TOLVAPTAN, TOLVAPTAN, TOLVAPTAN, TOLVAPTAN, ARIPIPRAZOLE, ATORVASTATIN CALCIUM, MIRTAZAPINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 568 | 26429190 |
US |
78 | 2 |
Limb injury, Mobility decreased, Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 569 | 26429378 |
US |
1 | |
Blood glucose increased, Incorrect dose administered, Glycosylated haemoglobin increased, |
||||
INSULIN LISPRO, |
||||
| 570 | 26430319 |
US |
37 | 2 |
Oedema peripheral, Blood glucose increased, Drug titration error, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LISINOPRIL, HYDROCHLOROTHIAZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LIRAGLUTIDE, |
||||
| 571 | 26430546 |
EU |
73 | 1 |
Type 1 diabetes mellitus, Blood glucose increased, Respiratory rate increased, Diabetic ketoacidosis, |
||||
DAPAGLIFLOZIN, CEMIPLIMAB-RWLC, CEMIPLIMAB-RWLC, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, AMLODIPINE BESYLATE, |
||||
| 572 | 26430998 |
US |
77 | 2 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 573 | 26431005 |
US |
59 | 1 |
Blood glucose decreased, Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 574 | 26420797 |
|||
Dementia, Blood glucose increased, |
||||
ROTIGOTINE, |
||||
| 575 | 26421352 |
JP |
74 | 1 |
Neuropathy peripheral, Blood glucose increased, Lung disorder, Glycosylated haemoglobin increased, KL-6 increased, Therapy partial responder, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
| 576 | 26421413 |
US |
71 | 2 |
Cataract, Renal disorder, Glycosylated haemoglobin increased, Muscle spasms, Glomerular filtration rate decreased, Pain, Blood creatinine increased, Depressed mood, Blood glucose increased, Haemoglobin decreased, Blood urea increased, Blood cholesterol increased, |
||||
IBRUTINIB, IBRUTINIB, LATANOPROST, TIMOLOL, HYDROCHLOROTHIAZIDE, ERGOCALCIFEROL, INSULIN GLARGINE, AMLODIPINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, EMPAGLIFLOZIN, IBRUTINIB, |
||||
| 577 | 26422222 |
US |
2 | |
Hypoglycaemia, Blood glucose increased, |
||||
INSULIN GLARGINE AND LIXISENATIDE, INSULIN LISPRO, |
||||
| 578 | 26422379 |
US |
2 | |
Blood glucose increased, Insomnia, Labelled drug-food interaction issue, |
||||
| 579 | 26422428 |
US |
77 | 1 |
Blood glucose increased, Blood urea increased, Blood creatinine increased, Glomerular filtration rate decreased, Protein total decreased, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 580 | 26422577 |
US |
68 | 2 |
Drug ineffective, Blood glucose increased, Feeling abnormal, |
||||
DULAGLUTIDE, |
||||
| 581 | 26422580 |
US |
15 | 1 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 582 | 26422665 |
EU |
76 | 1 |
Asphyxia, Nasopharyngitis, Condition aggravated, Blood glucose increased, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 583 | 26422862 |
US |
2 | |
Blood glucose increased, Blood calcium increased, Renal disorder, |
||||
CAPIVASERTIB, PANTOPRAZOLE, ANASTROZOLE, ANASTROZOLE TABLETS, GABAPENTIN, |
||||
| 584 | 26422901 |
GB |
2 | |
Malaise, Blood glucose increased, |
||||
ALPELISIB, |
||||
| 585 | 26423296 |
ZA |
67 | 1 |
Renal impairment, Pain in extremity, Blood glucose increased, |
||||
INSULIN GLULISINE, |
||||
| 586 | 26423390 |
GB |
2 | |
Blood glucose increased, Malaise, |
||||
ALPELISIB, |
||||
| 587 | 26423570 |
EU |
76 | 2 |
Malaise, Blood glucose increased, Device mechanical issue, Wrong technique in product usage process, Product storage error, Product leakage, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 588 | 26423595 |
US |
64 | 2 |
Blood glucose increased, Device mechanical issue, Visual impairment, |
||||
INSULIN GLARGINE, |
||||
| 589 | 26424042 |
US |
62 | 1 |
Blood glucose increased, Cataract, Product storage error, |
||||
DULAGLUTIDE, |
||||
| 590 | 26424044 |
US |
46 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 591 | 26424389 |
CA |
2 | |
Diverticulitis, Feeding disorder, Hypoglycaemia, Blood glucose increased, Illness, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SEMAGLUTIDE, INSULIN GLARGINE, |
||||
| 592 | 26424498 |
US |
64 | 1 |
Expired product administered, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN LISPRO, SEMAGLUTIDE, ORAL SEMAGLUTIDE, INSULIN GLARGINE, |
||||
| 593 | 26424661 |
US |
78 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO-AABC, |
||||
| 594 | 26424869 |
US |
47 | 2 |
Product dose omission issue, Blood glucose increased, Visual impairment, |
||||
INSULIN GLARGINE, |
||||
| 595 | 26424903 |
EU |
2 | |
Cerebral ischaemia, Hemiplegia, Carotid artery occlusion, Blood sodium decreased, Blood glucose increased, Gamma-glutamyltransferase increased, Aphasia, Dysarthria, Off label use, Aspartate aminotransferase increased, Alanine aminotransferase increased, |
||||
ABEMACICLIB, ABEMACICLIB, LISINOPRIL, CALCIUM, CALCIUM, LEUPROLIDE ACETATE, LETROZOLE, LETROZOLE TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ATORVASTATIN CALCIUM, AMLODIPINE, |
||||
| 596 | 26425186 |
MY |
66 | 2 |
Renal disorder, Blood glucose increased, |
||||
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, |
||||
| 597 | 26425281 |
US |
70 | 2 |
Blood glucose increased, |
||||
| 598 | 26425282 |
US |
64 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 599 | 26425386 |
US |
70 | 2 |
Retinal tear, Incorrect dose administered, Wrong technique in product usage process, Visual impairment, Eyelid oedema, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 600 | 26425443 |
US |
2 | |
Spinal fracture, Blood glucose increased, Decreased appetite, |
||||
CAPIVASERTIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28